Hyperphosphatemic Familial Tumoral Calcinosis With Galnt3 Mutation: Transient Response to Anti‐Interleukin‐1 Treatments by Astrid Dauchez, Camille Souffir, Pierre Quartier, Geneviève Baujat, Karine Briot, Christian Roux

Get full text

Evaluation of long-term TNFi effectiveness after a first switch in early axial spondyloarthritis considering time-varying prescription bias: an inverse-probability weighting analys... by Maxime Dougados, Anna Molto, Maria-Antonietta D’Agostino, Christian Roux, Karine Briot, Sylvie Chevret, Marion Pons

Get full text

High rate of progression to symptomatic multiple myeloma in patients with smoldering myeloma and isolated osteoporotic vertebral fracture by Kevin Chevalier, Sabrina Hamroun, Samuel Bitoun, Julien Henry, Christian Roux, Karine Briot, Rakiba Belkhir, Xavier Mariette, Raphaèle Seror

Get full text

Real‐World Effectiveness of Osteoporosis Medications in France: A Nationwide Cohort Study by Pauline Bosco‐Lévy, Karine Briot, Nadia Mehsen‐Cetre, James O'Kelly, Gaëlle Désaméricq, Abdelilah Abouelfath, Régis Lassalle, Angela Grelaud, Adeline Grolleau, Patrick Blin, Cécile Droz‐Perroteau

Get full text

Anticipated effects of burosumab treatment on long-term clinical sequelae in XLH: expert perspectives by Lothar Seefried, Martin Biosse Duplan, Martin Biosse Duplan, Martin Biosse Duplan, Karine Briot, Michael T. Collins, Rachel Evans, Pablo Florenzano, Pablo Florenzano, Neil Hawkins, Muhammad Kassim Javaid, Robin Lachmann, Leanne M. Ward

Get full text

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment by Karine Briot, Wei Sun, Rachel K Crowley, Maria Luisa Brandi, Stuart H Ralston, Peter Kamenický, Martine Cohen-Solal, Richard Keen, Angela Williams, Muhammad K Javaid, Robin H Lachmann, Annabel Nixon, Mark Nixon, Anne-Lise Lecoq, Sami Kolta, Jennifer S Walsh, Angela J Rylands

Get full text

Prevention and management of osteoporotic fractures by non-physician health professionals: a systematic literature review to inform EULAR points to consider by Cyrus Cooper, Tanja A Stamm, Karine Briot, Paul Studenic, Petra Balážová, Margot Bakkers, Mark Baxter, Jo Adams, Willem Lems, Nicky Wilson, Emailie Hurkmans, Anne-Birgitte Blavnsfeldt, Catharina Chiari, Razvan Dragoi, Gabriele Gäbler, Erika Mosor, Sandra Pais, Cornelia Simon, Simon Tilley, Jenny de la Torre

Get full text

Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis by Annemieke M. Boot, Gema Ariceta, Signe Sparre Beck-Nielsen, Maria Luisa Brandi, Karine Briot, Carmen de Lucas Collantes, Sandro Giannini, Dieter Haffner, Richard Keen, Elena Levtchenko, M. Zulf Mughal, Outi Mӓkitie, Ola Nilsson, Dirk Schnabel, Liana Tripto-Shkolnik, M. Carola Zillikens, Jonathan Liu, Alina Tudor, Francesco Emma

Get full text

The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data by Gema Ariceta, Signe Sparre Beck-Nielsen, Annemieke M. Boot, Maria Luisa Brandi, Karine Briot, Carmen de Lucas Collantes, Francesco Emma, Sandro Giannini, Dieter Haffner, Richard Keen, Elena Levtchenko, Outi Mӓkitie, M. Zulf Mughal, Ola Nilsson, Dirk Schnabel, Liana Tripto-Shkolnik, Jonathan Liu, Angela Williams, Sue Wood, M. Carola Zillikens

Get full text